Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

UNICEF: J8 Meets G8
Fourteen young people from countries attending the G8 called on their respective leaders to get tough with countries who don"t meet climate change targets and teachers whose standards slip.
generic viagra online
Mathematical Model Shows Why Defeating Insurgent Groups Like Taliban Is So Difficult
Insurgent groups like the Taliban can only be effectively engaged with timely and accurate military intelligence, and even good intelligence may only succeed in containing the insurgency, not defeating it, according to a new study in the current issue of Operations Research, a flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS®).
News of the day
Picks For NIH Head, Surgeon General Side With Obama On Reproductive Issues, Despite Faith
Francis Collins, President Obama"s pick to head NIH, and Regina Benjamin, Obama"s surgeon general nominee, have spoken publicly about their religious beliefs but also have expressed views on issues such as embryonic stem cell research that conflict with church teachings, USA Today reports. Collins, who headed the Human Genome Project, is an evangelical Christian who supports the use of human embryonic stem cells in some medical research. Focus on the Family in a newsletter lauded Obama"s choice of an evangelical to lead NIH but said that abortion-rights opponents cannot support Collins" views, "particularly since he supports destructive human embryonic stem cell research."Benjamin is a Roman Catholic and sits on the board of the Catholic Health Association. She also is active in her local church and received a papal medal in 2006. According to USA Today, Catholic leaders from her native state of Alabama say they have not heard Benjamin voice support for abortion rights. The Bayou La Batre, La., medical clinic that she oversees does not perform abortions. Bill Donohue, president of the Catholic League, initially expressed support for Benjamin"s nomination, saying, "Her tireless and selfless efforts are a model for all physicians." He later said that he opposes any possible support she might give "mandated abortion coverage" in health reform.The White House has said that Benjamin agrees with Obama "on reproductive issues." Retired archbishop Oscar Lipscomb, who nominated Benjamin for the papal medal, said, "She is a practicing Catholic and faithful and, to the best of my knowledge, in all those questions that have arisen so far, there has never been a conflict in her practice and in her conversation with regard to what the church expects of medical practitioners." Former Surgeon General David Satcher, who taught Benjamin at Morehouse School of Medicine, said, "While the religion of the surgeon general may very well influence his or her ... approach, the message has to be the public health science," adding, "It"s not a religious message. It"s a public health science message."Emilie Townes, associate dean of academic affairs for Yale Divinity School, said that Obama"s choices represent his aim to "break the mold" of traditional politics, adding that Collins and Benjamin are examples of "big tent" evangelicalism and Catholicism (Banks, USA Today, 8/3).
Mental Health

European Medicines Agency Launches Public Consultation On New Transparency Policy

The European Medicines Agency is inviting comments on its draft transparency policy until 25 September 2009. Since its inauguration in 1995, the Agency has worked continuously to improve the transparency of its operations, often extending the levels of transparency beyond the existing legal requirements. Bringing together all these initiatives, the new draft transparency policy describes for the first time in one comprehensive document the Agency"s vision on its level of openness towards its stakeholders. The policy proposes to focus on three main objectives for achieving a robust and consistent approach towards transparency in all areas of its activity: -- To make the daily operations of the Agency more transparent: this will not only include a re-assessment of the currently applied balance between transparency and protection of commercially confidential information, but will also lead to more proactive disclosure of information about the scientific evaluation of medicines. All of this will help to better explain how the Agency operates and how it reaches its scientific conclusions. -- To strengthen the Agency"s interaction with its stakeholders, in particular patients and healthcare professionals: the existing interaction will be further developed with a view to consulting patients and healthcare professionals on the scientific evaluation of medicines at the level of the Agency"s scientific committees. -- To promote a harmonised approach to transparency across the European medicines network: the Agency will be working closely with the medicines regulatory authorities in the EU Member States to provide for a harmonised approach to transparency, including consistent implementation across the European Union. As part of the public consultation process, the Agency will be holding a second workshop on transparency, in October 2009, to analyse and review all comments and feedback received. The draft transparency policy will be updated accordingly before its final adoption and publication, which is currently planned for the end of 2009. Notes 1. The draft EMEA transparency policy can be found here. 2. All comments should be sent using the comments form provided here. 3. The second workshop on development of the EMEA transparency policy is scheduled to take place at the EMEA on 19 October 2009. Details will be provided, closer to the time, in the "Events" section of the Agency"s website. EMEA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009